The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE HYPOMANIC ALERT: A PROGRAM DESIGNED FOR GREATER THERAPEUTIC CONTROL

Published Online:https://doi.org/10.1176/ajp.122.3.295

A program is described for the rapid detection and control of hypomanic episodes. This program has four salient features.

1. A systematic search for a pathognomonic tell-tale sign in each patient which heralds the onset of an attack.

2. The education of the patient and his family to the importance of detecting and reporting such signs or even suspicions of impending signs without delay.

3. The use of ancillary personnel to maintain regular monthly contacts with the patient and the family during symptom-free periods and to provide additional clinical observations. This program provides a financial saving for the patient and a reduction of the time demand on the psychiatrist while maintaining therapeutic efficiency.

4. The carefully controlled, intensive and early use of LiCO3 as the primary approach to alleviate hypomanic states. Lithium therapy approaches 100 percent effectiveness if used at the first sign of a hypomanic attack.

This program has proven both successful and practical for the management of a condition previously considered very difficult to treat.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.